The Growth Direct System automates microbial quality control testing in pharmaceutical manufacturing — the kind of environment where a contamination event can halt production, compromise patient safety, and trigger regulatory action. The software running these labs had to meet FDA's 21 CFR Part 11 compliance requirements: every action logged, every decision traceable.

I joined Rapid Micro Biosystems to redesign RMBNucleus™ — the web-based admin interface and the embedded touchscreen on the instrument itself. The existing system had been built by engineers without a dedicated designer. I started with a full UX audit, ran usability testing on internal staff, and worked through wireframes before building a component library that covered both interfaces.